Investor Relations

BioSig Issues Letter to Shareholders September 2018

Latest Financial Results

Q3 2018

Quarter Ended Sep 30, 2018

Latest 10-K

View Latest 10-K

Stock Information


Nasdaq: BSGM




52 week Low/High

Day Low/High

Company Overview

BioSig Technologies is a medical device company developing a proprietary technology platform designed to improve the $4 billion electrophysiology (EP) marketplace.

Investor Relations

T: (866) 976-4784

Transfer Agent

Action Stock Transfer
Justeene Blankenship
2469 E. Fort Union Blvd
Suite 214
Salt Lake City, UT 84121
T: (801) 274-1088